Market Overview - The U.S. stock market showed subdued performance, with the Dow Jones Industrial Average increasing by 0.11% to 49,071.56, while the S&P 500 decreased by 0.13% to 6,969.01, and the Nasdaq Composite fell by 0.72% to 23,685.12 [1] - The technology sector experienced a significant sell-off, particularly in Microsoft Corporation (MSFT) shares, due to concerns over slower cloud growth, although Meta provided some offsetting strength [2] Value Stocks Analysis - Value stocks are highlighted as appealing investment opportunities amid cautious market sentiment, driven by rising oil prices and geopolitical tensions [2] - The Price to Cash Flow (P/CF) ratio is emphasized as an effective valuation metric, indicating that a lower P/CF ratio suggests better value and strong cash generation potential [3][4] - Analysts note that cash flow is a more reliable indicator of a company's financial health compared to earnings, which can be influenced by accounting estimates and management manipulation [5] Investment Strategy - A comprehensive investment strategy should include multiple valuation metrics such as price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio, alongside a favorable Zacks Rank and Value Score [7] - Parameters for selecting true-value stocks include a P/CF ratio less than or equal to the industry median, a minimum stock price of $5, and an average 20-day trading volume greater than 100,000 [8] Selected Value Stocks - Four companies—Harmony Biosciences Holdings, Inc. (HRMY), Universal Health Services, Inc. (UHS), Concentrix Corporation (CNXC), and Global Payments Inc. (GPN)—meet strict value criteria, showing low P/CF ratios and solid financial health [9] - Each of these companies is projected to grow both sales and earnings per share (EPS) in the current financial year, with all carrying a Value Score of A and demonstrating consistent positive earnings surprises [9] Company-Specific Insights - Harmony Biosciences is projected to see sales growth of 21.4% and EPS growth of 25.9% for the current financial year, despite a 4.9% decline in share price over the past year [13] - Universal Health Services anticipates sales growth of 9.7% and EPS growth of 31.3%, with shares rising by 6.1% in the past year [14] - Concentrix Corporation expects sales growth of 2.9% and EPS growth of 4.8%, although its shares have dropped by 26.1% in the past year [15] - Global Payments forecasts sales growth of 1.8% and EPS growth of 5.8%, with shares declining by 36.8% over the past year [16]

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get starte ...

Welcome to Investing Insights. I'm your host, Ivana Hampton. Emerging market funds will have a tough act to follow in 2026.The category racked up big gains last year following small returns for years, and a mix of factors like trade tensions prompted many investors to shift their dollars outside the US. Should you add emerging market funds to your portfolio and which ones were winners or losers. Morning Star's senior principal of ratings, Russ Kennel, dug into the data.The editor of the fund investor newsle ...

Core Viewpoint - The investment strategy is informed by a background in the oil and gas sector, emphasizing efficiency, carefulness, and discipline in decision-making [1] Investment Focus - The company has a sustained interest in U.S. equity markets, particularly in technology, energy, and healthcare sectors [1] - The investment approach has evolved from growth investing to a blend of value and growth, focusing on the underlying economics of businesses [1] Competitive Advantage - There is an emphasis on evaluating the durability of a company's competitive advantage, referred to as its "moat," and its ability to generate consistent free cash flow over time [1] Investment Philosophy - The philosophy includes a conservative orientation, seeking to minimize downside risk while looking for upside potential [1] - As retirement approaches, there is a shift towards prioritizing income-generating assets such as dividend-paying equities and REITs [1] Community Engagement - The company values participation in a community of investors to share insights on real-world business fundamentals and intelligent investing [1] - There is a commitment to investing in ecologically sensitive businesses, reflecting a broader concern for environmental impact [1]

One of my concerns with Apple Inc. ( AAPL ), which led me to give it a Sell rating recently, was its lack of innovation, which in turn impacted top-line growth and my expectations for valuation. ForEquity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for collaborations or to connect!Analyst’s Disclosure: ...

Core Viewpoint - The article compares Oddity Tech (ODD) and Adyen N.V. Unsponsored ADR (ADYEY) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Estimates - Oddity Tech has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Adyen N.V. has a Zacks Rank of 4 (Sell), suggesting a less favorable earnings outlook [3] - The Zacks Rank system emphasizes companies with strong earnings estimate revisions, making ODD a more appealing option for investors focused on earnings growth [3] Group 2: Valuation Metrics - ODD has a forward P/E ratio of 13.87, significantly lower than ADYEY's forward P/E of 32.33, indicating that ODD may be undervalued compared to ADYEY [5] - The PEG ratio for ODD is 1.16, while ADYEY's PEG ratio is 1.76, suggesting that ODD offers better value relative to its expected earnings growth [5] - ODD's P/B ratio is 4.91, compared to ADYEY's P/B of 9.06, further supporting the notion that ODD is more attractively priced [6] Group 3: Value Grades - ODD has a Value grade of B, while ADYEY has a Value grade of F, indicating that ODD is viewed more favorably by value investors based on key fundamental metrics [6]

Core Viewpoint - The article compares Hackett Group (HCKT) and Equifax (EFX) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - Hackett Group has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to Equifax, which has a Zacks Rank of 4 (Sell) [3] - HCKT has likely experienced a stronger improvement in its earnings outlook than EFX recently [3] Group 2: Valuation Metrics - HCKT has a forward P/E ratio of 10.83, significantly lower than EFX's forward P/E of 23.71 [5] - HCKT's PEG ratio is 0.98, while EFX's PEG ratio is 2.08, indicating HCKT is more favorably valued in terms of expected earnings growth [5] - HCKT has a P/B ratio of 5.04, slightly lower than EFX's P/B of 5.07, suggesting comparable valuation in terms of book value [6] Group 3: Value Grades - Based on various valuation metrics, HCKT holds a Value grade of A, while EFX has a Value grade of C, indicating HCKT is viewed as more undervalued [6] - HCKT's stronger estimate revision activity and more attractive valuation metrics suggest it is the superior option for value investors at this time [7]

Investors looking for stocks in the Waste Removal Services sector might want to consider either Veolia Environnement SA (VEOEY) or Waste Management (WM) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on ...

Core Viewpoint - Investors are evaluating the value opportunities presented by BNP Paribas SA (BNPQY) and Banco Itau (ITUB) in the foreign banking sector, with BNPQY currently appearing as the superior value option based on various valuation metrics [1][7]. Group 1: Zacks Rank and Earnings Outlook - Both BNP Paribas SA and Banco Itau hold a Zacks Rank of 1 (Strong Buy), indicating positive revisions to their earnings estimates and improving earnings outlooks [3]. - The Zacks Rank system is designed to favor stocks with strong earnings estimate revision trends, which is a key consideration for investors [2]. Group 2: Valuation Metrics - BNPQY has a forward P/E ratio of 7.81, while ITUB has a forward P/E of 10.59, suggesting that BNPQY may be undervalued compared to ITUB [5]. - The PEG ratio for BNPQY is 0.77, indicating a favorable valuation when considering expected earnings growth, whereas ITUB has a PEG ratio of 1.06 [5]. - BNPQY's P/B ratio is 0.79, which is significantly lower than ITUB's P/B of 2.38, further supporting the argument that BNPQY is undervalued [6]. - Based on these valuation metrics, BNPQY holds a Value grade of A, while ITUB has a Value grade of D, highlighting the relative attractiveness of BNPQY [6].

Core Viewpoint - Investors in the Mining - Miscellaneous sector should consider Glencore PLC (GLNCY) and Ivanhoe Mines Ltd. (IVPAF) as potential undervalued stocks, with GLNCY appearing to be the superior option based on various valuation metrics [1][7]. Valuation Metrics - GLNCY has a forward P/E ratio of 20.78, while IVPAF has a significantly higher forward P/E of 35.96 [5]. - The PEG ratio for GLNCY is 1.07, indicating a favorable valuation relative to its expected earnings growth, compared to IVPAF's PEG ratio of 1.12 [5]. - GLNCY's P/B ratio stands at 2.53, which is lower than IVPAF's P/B ratio of 3.5, suggesting that GLNCY is more attractively priced relative to its book value [6]. Earnings Outlook - GLNCY has shown a stronger improvement in its earnings outlook compared to IVPAF, which is a critical factor for value investors [3][7]. - The overall valuation figures and solid earnings outlook position GLNCY as the better value option in the current market [7].